Cited by 119Cytokine Signaling Pathways and InteractionsPsoriasis: Treatment and PathogenesisAntifungal resistance and susceptibility

Oral epithelial IL-22/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis

Open access
Aggor, Felix E. Y., Break, Timothy J., Trevejo-Nuñez, Giraldina, Whibley, Natasha, Coleman, Bianca M., Bailey, Rachel D., Kaplan, Daniel H., Naglik, Julian R. +9 more·2020·Science Immunology

Abstract

IL-22 signaling limits oral candidiasis via proliferation of basal epithelial cells and replenishment of an IL-17–responsive layer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciimmunol.aba0570

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-22 appears dispensable for immunity in the setting of skin C. auris colonization, although it is critical for protection against C. albicans oral infection.

    “The type-17 cytokine, IL-22, although critical for protection against C. albicans oral infection, appears dispensable for immunity in the setting of skin C. auris colonization [3,94].”

    From Host–Candida auris interactions in the skin (2026) · cites this paper as [94]

    The Results section reports that IL-22-deficient mice remained susceptible to oral C. albicans infection while wild-type mice cleared it, supporting the oral-protection part of the sentence. The paper does not address whether IL-22 is dispensable during skin C. auris colonization; its discussion of skin candidiasis concerns C. albicans, not C. auris. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

8 of the 123 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. [13]Ho A, IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. J. Immunol 185, 1063– 1070 (2010). 20554964 PMC2897912
  2. [23]Moyes DL, A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells. Cell Host Microbe 8, 225– 235 (2010). 20833374 PMC2991069
  3. [31]Conti H, IL-17RA signaling in oral epithelium is critical for protection against oropharyngeal candidiasis. Cell Host Microbe 20, 606– 617 (2016). 27923704 PMC5147498
  4. [64]Wolk K, Witte E, Witte K, Warszawska K, Sabat R, Biology of IL-22. Semin Immunol 32, 17– 31 (2010). 20127093

Cited by

Sorted by citations

Authors
Aggor, F. E. Y., Break, T. J., Trevejo-Nuñez, G., Whibley, N., Coleman, B. M., Bailey, R. D., Kaplan, D. H., Naglik, J. R., Shan, W., Shetty, A. C., McCracken, C., Durum, S. K., Biswas, P. S., Bruno, V. M., Kolls, J. K., Lionakis, M. S., & Gaffen, S. L.
Affiliations
  • University of Pittsburgh (US)
  • National Institutes of Health (US)
  • King's College London (GB)
  • University of Maryland, Baltimore (US)
  • Tulane University (US)
Corresponding author
Gaffen, Sarah L.
Venue
Science Immunology
Published
2020-06-26
Volume
5
Issue
48
ISSN
2470-9468 (ISSN-L)
OpenAlex
W3034031851
Cited by
119
References
123
Citations by year
2026: 16 · 2025: 20 · 2024: 18 · 2023: 21 · 2022: 24 · 2021: 17 · 2020: 3
FWCI
5.87
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Science Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (acceptedVersion, other-oa)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (HL135476, HL139930)
  • National Institute of Allergy and Infectious Diseases (AI110820, AI107825)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK104680)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR071720, AR060744)
  • Wellcome (214229_Z_18_Z)
  • King’s College Hospital NHS Foundation Trust (IS-BRC-1215-20006)
  • National Institute of Dental and Craniofacial Research (DE022550, DE02815)
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Keywords
IL-22, IL-17, STAT3, oral candidiasis, oral epithelium, IL-22RA1, IL-17RA, antifungal immunity, epithelial regeneration, tongue
MeSH terms
Interleukin-22, Animals, Candida albicans, Candidiasis, Oral, Epithelial Cells, Female, Interleukins, Male, Mice, Inbred C57BL, Mouth Mucosa, Signal Transduction, Mice, Knockout, Interleukin-17, STAT3 Transcription Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review